Pharmacogenomic testing and response to warfarin

被引：11
|
作者：
Wu, Alan H. B. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Lab Med, San Francisco, CA 94110 USA
来源：
LANCET | 2015年 / 385卷 / 9984期
关键词：
D O I：
10.1016/S0140-6736(14)62219-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2231 / 2232
页数：2
相关论文
共 50 条
  • [1] Pharmacogenomic Testing and Warfarin Management
    Maluso, Andrea
    [J]. ONCOLOGY NURSING FORUM, 2015, 42 (05) : 563 - 565
  • [2] Warfarin pharmacogenomic testing platforms
    Wu, Alan H. B.
    [J]. PHARMACOGENOMICS, 2008, 9 (08) : 1002 - 1003
  • [3] Warfarin and pharmacogenomic testing: The case for restraint
    Garcia, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 303 - 305
  • [4] Warfarin and Pharmacogenomic Testing: What Would Pascal Do?
    Teagarden, J. Russell
    [J]. PHARMACOTHERAPY, 2009, 29 (03): : 245 - 247
  • [5] A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
    Lisa M. Meckley
    James M. Gudgeon
    Jeffrey L. Anderson
    Marc S. Williams
    David L. Veenstra
    [J]. PharmacoEconomics, 2010, 28 : 61 - 74
  • [6] A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing
    Meckley, Lisa M.
    Gudgeon, James M.
    Anderson, Jeffrey L.
    Williams, Marc S.
    Veenstra, David L.
    [J]. PHARMACOECONOMICS, 2010, 28 (01) : 61 - 74
  • [7] Pharmacogenomic Testing and Warfarin What Evidence Has the GIFT Trial Provided?
    Emery, Jon D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (12): : 1110 - 1112
  • [8] Pharmacogenomic testing and antidepressant response: problems and promises
    Smith, Tawny L.
    Nemeroff, Charles B.
    [J]. BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (02) : 116 - 117
  • [9] Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin
    Shahabi, Payman
    Siest, Gerard
    Visvikis-Siest, Sophie
    [J]. PHARMACOGENOMICS, 2012, 13 (11) : 1215 - 1218
  • [10] Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
    Frye, Mark A.
    Nemeroff, Charles B.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2024, 49 (05) : 770 - 771
12345